drugset / Trial / NCT07104682
A Study to Determine the Safety and Effectiveness of the Investigational Cellular Therapy GCAR1 in a Patient With Alveolar Soft Part Sarcoma
NaSingle-groupOpen-labelTreatment
Summary
A single patient study to determine whether GCAR1 is safe and effective for refractory, progressive metastatic alveolar soft part sarcoma (ASPS).
Timeline
- Start
- 2025-08-08
- Primary completion
- 2026-11-30
- Completion
- 2026-11-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GCAR1 | Cell therapy | 5e+06 cells/kg | Intravenous |